Novel monoclonal antibodies showing broad neutralizing activity for SARS-CoV-2 variants including Omicrons BA.5 and BA.2.75
H. Ishimaru, M. Nishimura, L. H. Tjan, S. Sutandhio, M. I. Marini, G. B. Effendi, H. Shigematsu, K. Kato, N. Hasegawa, K. Aoki, Y. Kurahashi, K. Furukawa, M. Shinohara, T. Nakamura, J. Arii, , Y. Mori
bioRxiv · Sep 2, 2022 · PreprintMicrobiology